ABCC1 and non-small cell lung carcinoma: Afterward, we analyzed the expression of the TFEB, ABCA1 and ABCC1 in a panel of 6 NSCLC cell lines, with a different degree of resistance to cisplatin and to Vγ9Vδ2 T-lymphocyte immuno-killing [15].